OLYS Pharma

La Hulpe ·KBO/BCE: BE 0754.895.372

Loading dossier…

Checked · Insight, alerts and connections for every Belgian company, from official sources.

NL FR EN

Product

Search companies Sectors Radar Live Compare Prospects Supplier check Feasibility

Data & registers

Insolvencies Curators Directors Director bans Protection orders Notaries News

Account

Watchlist Portfolio Alerts Pricing

Checked

About Methodology Knowledge base Sources FAQ Help API Badge

Legal

Privacy Terms Contact

Checked AI

Open a company dossier to ask Checked AI about it.

Answers from Checked AI. Not legal advice.

Metric	This company	Sector median	Position in the sector
Solvency	54.7%	46.9%	better than 53% of 46 sector peers
Net result	€534k	€-1k	better than 92% of 46 sector peers
Equity	€565k	€108k	better than 71% of 46 sector peers
Gross operating margin	€635k	€28k	better than 90% of 42 sector peers
Total assets	€1.03M	€284k	better than 64% of 46 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€1.03M
Fixed assets	21/28	€840k
Formation expenses	20	€228
Intangible fixed assets	21	€840k
Tangible fixed assets	22/27	€408
Current assets	29/58	€192k
Stocks & contracts in progress	3	€7k
Amounts receivable within one year	40/41	€18k
Cash & bank	54/58	€167k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€1.03M
Equity	10/15	€565k
Contributions / capital	10/11	€496k
Accumulated profits (losses)	14	€-106k
Amounts payable	17/49	€468k
Amounts payable after one year	17	€200k
Amounts payable within one year	42/48	€268k
Trade debts payable within one year	44	€17k
Income statement
Gross operating margin	9900	€635k
Operating result	9901	€545k
Financial income	75	€5k
Financial charges	65	€16k
Result before taxes	9903	€534k
Net result for the period	9904	€534k
Result to be appropriated	9905	€534k

Summary